Download PDF
Erfahrungsheilkunde 2014; 63(6): 332-339
DOI: 10.1055/s-0034-1395803
Wissen
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Die Life-SMS-Methodik

Lebensstilkonzept bei Multipler Sklerose
Jörg Spitz
,
Anno Jordan
Further Information

Publication History

Publication Date:
16 December 2014 (online)

    Permissions and Reprints

Zusammenfassung

Die MS wird von zahlreichen genetischen und Umweltfaktoren beeinflusst. Klassische, schulmedizinische Behandlungsansätze versprechen bisher allenfalls eine Abschwächung des Verlaufs. Das Projekt Life-SMS (Lebensstil-Strategien bei MS) betrachtet das Thema MS unter einem systemischen Ansatz. Auf Basis verfügbarer wissenschaftlicher Studien zum Themenkomplex Lebensstil, Umwelteinflüsse und Stabilisierung des Systems Mensch − speziell des Immunsystems − wird eine Methodik entwickelt, die unabhängig von und kompatibel mit jeglichen medikamentösen Therapien ist. Die Life-SMS-Methodik eröffnet Betroffenen die Möglichkeit, eigenverantwortlich mit der Krankheit umzugehen und das Paradigma des progressiven Verlaufs zu überwinden.

Abstract

MS is influenced by numerous genetic and environmental factors. Up to now, only a mitigation of the course of the disease can be achieved with classical treatment approaches of orthodox medicine. The project Life-SMS (lifestyle strategies in the case of MS) deals with the topic MS using a systemic approach. Based on existing scientific studies on the topics of lifestyle, environmental influences, and stabilization of the human system − especially of the immune system − a methodology is developed, which is independent of and compatible with any drug therapy. The methodology of Life-SMS allows the people affected, to deal with the disease on their own responsibility and to overcome the paradigm of the progressive course.

Schlüsselwörter

Life-SMS-Methodik - MS - Lebensstilmaßnahmen - Selbsthilfe

Keywords

Methodology of Life-SMS - MS - lifestyle measures - self-help
 

  • Literatur

  • 1 Corthals AP. Multiple sclerosis is not a disease of the immune system. The Quarterly Review of Biology 2011; 86: 287-321
    CrossrefPubMedSearch in Google Scholar
  • 2 http://www.overcomingmultiplesclerosis.org/ George Jelinek NHMRC Clinical Centre for Research Excellence in Diabetes, Department of Medicine, University of Melbourne (St Vincent’s Health).
    PubMed
  • 3 Jelinek G. Overcoming multiple sclerosis. An evidence-based guide to recovery. Sidney: Allen & Unwin; 2010
    Search in Google Scholar
  • 4 Hadgkiss E, Jelinek GA, Weiland TJ et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2012;
    PubMedSearch in Google Scholar
  • 5 Marrie RA, Rudick R, Horwitz R. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010; 74: 1041-1047
    CrossrefPubMedSearch in Google Scholar
  • 6 Oliveira SR, Simão ANC, Kallaur AP et al. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition 2014; 30: 268-273
    CrossrefPubMedSearch in Google Scholar
  • 7 Ringe JD, Kipshoven C. Vitamin D-insufficiency: An estimate of the situation in Germany. dermatoendocrinology 2012; 4: 72-80
    CrossrefPubMedSearch in Google Scholar
  • 8 Correale J, Farez MF. Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid. Journal of Neuroimmunology 2013; 261: 134-140
    CrossrefPubMedSearch in Google Scholar
  • 9 Pierrot-Deseilligny C, Souberbielle JC. Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Therapeutic Advances in Neurological Disorders 2013; 6: 81-116
    CrossrefPubMedSearch in Google Scholar
  • 10 Stewart N, Simpson S, van der Mei I et al. Interferon- and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Neurology 2012; 79: 254-260
    CrossrefPubMedSearch in Google Scholar
  • 11 Scott TF, Hackett CT, Dworek DC et al. Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients. J Neurol Sci 2013; 330: 27-31
    CrossrefPubMedSearch in Google Scholar
  • 12 Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008; 233: 674-688
    CrossrefPubMedSearch in Google Scholar
  • 13 van Meeteren ME, Teunissen CE, Dijkstra CD et al. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr 2005; 59: 1347-1361
    CrossrefPubMedSearch in Google Scholar
  • 14 Aggarwal BB, Prasad S, Reuter S. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: „reverse pharmacology“ and „bedside to bench“ approach. Curr Drug Targets 2011; 12: 1595-1653
    CrossrefPubMedSearch in Google Scholar
  • 15 Döring A, Pfueller CF, Paul F. Exercise in multiple sclerosis − an integral component of disease management. EPMA Journal 2012; 3: 2-
    CrossrefPubMedSearch in Google Scholar
  • 16 Beier M, Bombardier CH, Hartoonian N. Improved physical fitness correlates with improved cognition in multiple sclerosis. Arch Phys Med Rehabil 2014;
    PubMedSearch in Google Scholar
  • 17 Ackerman KD. Stressful life events precede exacerbations of multiple sclerosis. Psychosomatic Medicine 2002; 64: 916-920
    PubMedSearch in Google Scholar
  • 18 Burns MN, Nawacki E, Kwasny MJ et al. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?. Psychol Med 2014; 44: 349-359
    CrossrefPubMedSearch in Google Scholar
  • 19 Oken BS, Kishiyama S, Zajdel D. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004; 62: 2058-2064
    CrossrefPubMedSearch in Google Scholar